최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Pediatric infection and vaccine: PIV, v.26 no.1, 2019년, pp.1 - 10
정지원 (울산대학교 의과대학 서울아산병원 소아청소년과) , 유리나 (울산대학교 의과대학 서울아산병원 소아청소년과) , 성흥섭 (울산대학교 의과대학 서울아산병원 진단검사의학과) , 김미나 (울산대학교 의과대학 서울아산병원 진단검사의학과) , 이진아 (울산대학교 의과대학 서울아산병원 소아청소년과)
Purpose: We investigated the distribution and antimicrobial resistance of pneumococcal isolates from hospitalized children at Asan Medical Center for recent 4 years, and aimed to recommend proper choice of empirical antibiotics for pneumococcal infection. Methods: From March 2014 to May 2018, childr...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
폐구균이란? | 폐구균은 영유아 및 소아에서 급성 중이염, 부비동염 및 폐렴, 수막염, 균혈증을 유발하는 중요 원인균이며, 65세 이상의 성인과 만성 질환자에서도 침습 감염증을 일으키는 주요한 세균이다. 1) 폐구균은 피막 다당원의 항원성에 따라 90여 종의 혈청형이 알려져 있으며, 이중 소아에서 침습성 감염을 일으키는 주된 혈청형은 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F 및 23F의 13가지로 알려져 있다. | |
폐구균 감염의 위험성은 2세 미만의 소아에서 증가하는 이유는? | 1) 폐구균은 피막 다당원의 항원성에 따라 90여 종의 혈청형이 알려져 있으며, 이중 소아에서 침습성 감염을 일으키는 주된 혈청형은 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F 및 23F의 13가지로 알려져 있다. 2) 폐구균 감염의 위험성은 2세 미만의 소아에서 증가하는데, 이는 비인두 집락률이 높으며 피막 다당에 대한 항체 반응이 감소되어 있기 때문이다. 주로 3–5개월에 수막염, 6–12개월에 중이염, 13–18개월에 폐렴의 발생빈도가 높게 나타난다. | |
월별로 폐구균 감염으로 발생하는 질병의 발생빈도는 어떻게 나타나는가? | 2) 폐구균 감염의 위험성은 2세 미만의 소아에서 증가하는데, 이는 비인두 집락률이 높으며 피막 다당에 대한 항체 반응이 감소되어 있기 때문이다. 주로 3–5개월에 수막염, 6–12개월에 중이염, 13–18개월에 폐렴의 발생빈도가 높게 나타난다. 2-5) |
Kim KH, Sohn YM, Kang JH, Kim KN, Kim DS, Kim JH, et al. The causative organisms of bacterial meningitis in Korean children, 1986-1995. J Korean Med Sci 1998;13:60-4.
Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 2005;5:83-93.
Tan TQ. Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev 2012;25:409-19.
Brandileone MC, Vieira VS, Casagrande ST, Zanella RC, Guerra ML, Bokermann S, et al. Prevalence of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated from Brazilian children with invasive infections. Pneumococcal study group in Brazil for the SIREVA project. Regional system for vaccines in Latin America. Microb Drug Resist 1997;3:141-6.
Mantese OC, Paula A, Almeida VV, Aguiar PA, Wolkers PC, Alvares JR, et al. Prevalence of serotypes and antimicrobial resistance of invasive strains of pneumococcus in children: analysis of 9 years. J Pediatr (Rio J) 2009;85:495-502.
Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990;3:171-96.
Doern GV, Richter SS, Miller A, Miller N, Rice C, Heilmann K, et al. Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes? Clin Infect Dis 2005;41:139-48.
Song JH, Lee NY, Ichiyama S, Yoshida R, Hirakata Y, Fu W, et al. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis 1999;28:1206-11.
Weinstein MP, Klugman KP, Jones RN. Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance. Clin Infect Dis 2009;48:1596-600.
CLSI. Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement. CLSI document M100-S26. Wayne: Clinical and Laboratory Standards Institute, 2008.
Cho EY, Lee H, Choi EH, Kim YJ, Eun BW, Cho YK, et al. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolated from invasive infections after optional use of the 7-valent conjugate vaccine in Korea, 2006-2010. Diagn Microbiol Infect Dis 2014;78:481-6.
Vuori-Holopainen E, Peltola H, Kallio MJ; SE-TU Study Group. Narrow-versus broad-spectrum parenteral anatimicrobials against common infections of childhood: a prospective and randomised comparison between penicillin and cefuroxime. Eur J Pediatr 2000;159:878-84.
Paik JY, Choi JH, Cho EY, Oh CE, Lee J, Choi EH, et al. Antibiotics susceptability of Streptococcus pneumoniae isolated from pharynx in healthy Korean children and choice of proper empirical oral antibiotics using pharmacokinetics/pharmacodynamics model. Korean J Pediatr Infect Dis 2011;18:109-16.
Fallon RM, Kuti JL, Doern GV, Girotto JE, Nicolau DP. Pharmacodynamic target attainment of oral ${\beta}$ -lactams for the empiric treatment of acute otitis media in children. Paediatr Drugs 2008;10:329-35.
Jung YS. Antibiotics resistance of Streptococcus pneumoniae and Enterococcus sp. J Korean Soc Chemother 1993;11:48-55.
Friedland IR, Klugman KP. Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child 1992;146:920-3.
Pallares R, Linares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333:474-80.
Song JH, Jung SI, Ki HK, Shin MH, Ko KS, Son JS, et al. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in Asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens. Clin Infect Dis 2004;38:1570-8.
Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 2004;48:2101-7.
Torumkuney D, Chaiwarith R, Reechaipichitkul W, Malatham K, Chareonphaibul V, Rodrigues C, et al. Results from the survey of antibiotic resistance (SOAR) 2012-14 in Thailand, India, South Korea and Singapore. J Antimicrob Chemother 2016;71 Suppl 1:i3-19.
Cho EY, Kang HM, Lee J, Kang JH, Choi EH, Lee HJ. Changes in serotype distribution and antibiotic resistance of nasopharyngeal isolates of Streptococcus pneumoniae from children in Korea, after optional use of the 7-valent conjugate vaccine. J Korean Med Sci 2012;27:716-22.
Hyde TB, Gay K, Stephens DS, Vugia DJ, Pass M, Johnson S, et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA 2001;286:1857-62.
Song JH, Chang HH, Suh JY, Ko KS, Jung SI, Oh WS, et al. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP). J Antimicrob Chemother 2004;53:457-63.
Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era. JAMA 2001;285:1729-35.
Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007;196:1346-54.
Moore MR, Whitney CG. Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect? Clin Infect Dis 2008;46:183-5.
Yun KW, Choi EH, Lee HJ, Kang JH, Kim KH, Kim DS, et al. Genetic structures of invasive Streptococcus pneumoniae isolates from Korean children obtained between 1995 and 2013. BMC Infect Dis 2018;18:268.
Kim SH, Bae IK, Park D, Lee K, Kim NY, Song SA, et al. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing invasive and noninvasive pneumococcal diseases in Korea from 2008 to 2014. Biomed Res Int 2016;2016:6950482.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.